2′-Deoxy-2′-fluorocytidine

We are 2′-Deoxy-2′-fluorocytidine CAS:10212-20-1 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name:2'-Deoxy-2'-fluorocytidine
CAS.NO:10212-20-1
Synonyms:2'-FdC
4-Amino-1-[(2R,3R,4R,5R)-3-fluoro-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidin-2-one
2'-Deoxy-2'-fluoro-D-cytidine
2'-FLUORO-D-CYTIDINE; 2'-FC
Molecular Formula:C9H12FN3O4
Molecular Weight:245.20800
 
Physical and Chemical Properties:
Density:1.82
Melting point:167ºC
Boiling point:500.1ºC
Flash point:256.2ºC
 
Specification:
Appearance:White to off-white powder
Assay(HPLC):≥98.0%
Loss on drying:≤1.0%
Heavy metal:≤20ppm
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:2'-Deoxy-2'-fluorocytidine is a potent inhibitor of the subgenomic hepatitis C virus replicon in Huh-7 cells. 2'-Deoxy-2'-fluorocytidine has been shown to inhibit Borna Disease virus replication and spread.

2'-Deoxy-2'-fluorocytidine


Related News: Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.Ácido 4-metoxifenilacético CAS:104-01-8 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.3-glicidiloxipropil (dimetoxi) metilsilano CAS:65799-47-5 Many branded versions of drugs are currently more expensive in China than in other major markets. They could now be subjected to a centralized procurement program where manufacturers will have to go through a bidding process to get the right to supply drugs to public hospitals, the National Health Commission said in a document published on late Friday.DL-Leucine CAS:328-39-2 The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.The rigosertib Pre-approval Access Program is expected to launch in first half of 2020 and will allow Inceptua to supply intravenous rigosertib within designated countries, primarily and initially concentrated in selected countries in Europe, in response to physician requests for patients with higher-risk MDS who have exhausted all available treatment options, and are not eligible for or have no access to the INSPIRE study.

Related Products
Product Name
2-Methoxy-3-(trifluoromethyl)pyridine View Details
CBZ-ASP(OBZL)-OBZL View Details
Eledoisin View Details
10-bromobenzo[b]naphtho[1,2-d]furan manufacturer 4-phenoxybenzoic acid manufacturer 4′-Chloro-2′,5′-dimethoxyacetoacetanilide manufacturer 1-[2-(2-Hydroxyethoxy)Ethyl]Piperidine manufacturer 2,4-Difluoro-3-methylbenzonitrile manufacturer